Kunal Kumar - Concepedia

Author

Kunal Kumar

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Dr. Kunal Kumar, K. N. Mahesh Kumar, K.N. Mahesh Kumar, KUNAL KUMAR, Kara Beliard, Kunal Kumar

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Discovery Institute Stony Brook University Colorado State University AstraZeneca (United Kingdom)

About

Kunal Kumar is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	857
2	Natural Sciences	5	5	368
3	Biochemistry	5	5	368
4	Engineering	1	1	60
5	Health Sciences	1	1	24

Kunal Kumar

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Novel Trisubstituted Benzimidazoles, Targeting <i>Mtb</i> FtsZ, as a New Class of Antitubercular Agents Kunal Kumar, Divya Awasthi, Seung-Yub Lee, Journal of Medicinal Chemistry Pharmaceutical ScienceAntitubercular AgentsPharmacotherapyAntimicrobial ChemotherapyPharmaceutical Chemistry	2010	170
GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration Courtney Ackeifi, Peng Wang, Esra Karaköse, Science Translational Medicine Insulin SignalingCellular PhysiologyMolecular PharmacologyHuman Insulin SecretionSignaling Pathway	2020	116
Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation Kunal Kumar, Peng Wang, Roberto Sánchez, Journal of Medicinal Chemistry	2018	76
SAR Studies on Trisubstituted Benzimidazoles as Inhibitors of <i>Mtb</i> FtsZ for the Development of Novel Antitubercular Agents Divya Awasthi, Kunal Kumar, Susan E. Knudson, Journal of Medicinal Chemistry Lead CompoundsAntibacterial ActivityTrisubstituted BenzimidazolesLead IdentificationPharmacotherapy	2013	75
Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B Manoj Kale, Anandkumar Raichurkar, Shahul Hameed P, Journal of Medicinal Chemistry Antiparasitic AgentMolecular BiologyAntimicrobial ChemotherapyPharmaceutical ChemistryMtb Mic	2013	66
Usnic acid induces apoptosis in human gastric cancer cells through ROS generation and DNA damage and causes up-regulation of DNA-PKcs and γ-H2A.X phosphorylation Kunal Kumar, Jai P.N. Mishra, Rana P. Singh Chemico-Biological Interactions Cancer ResearchDna DamageRos GenerationMedicineApoptosis	2019	61
Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents Bora Park, Divya Awasthi, Soumya R. Chowdhury, Bioorganic & Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryEngineeringMedicineDrug Discovery	2014	60
Pharmacologic and genetic approaches define human pancreatic β cell mitogenic targets of DYRK1A inhibitors Courtney Ackeifi, Ethan Swartz, Kunal Kumar, JCI Insight Small Molecule InhibitorsDual SpecificityMolecular RegulationGenetic ApproachesMolecular Pharmacology	2019	55
Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor Kunal Kumar, Peng Wang, Jessica Wilson, Journal of Medicinal Chemistry	2020	51
Mancozeb selectively induces mitochondrial-mediated apoptosis in human gastric carcinoma cells through ROS generation Kunal Kumar, Akash Sabarwal, Rana P. Singh Mitochondrion Mitochondrial-mediated ApoptosisRos GenerationChemoprevention StrategyOncogenic AgentMedicine	2018	48

Page 1